Breakdown | ||||
Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
20.62B | 19.83B | 18.33B | 16.68B | 17.21B | Gross Profit |
20.62B | 20.63B | 18.33B | 16.68B | 17.21B | EBIT |
10.63B | 11.20B | 17.11B | 8.96B | 4.22B | EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
6.96B | 7.41B | 6.89B | 6.36B | 3.50B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
112.94B | 120.20B | 144.53B | 109.21B | 160.95B | Total Assets |
1.08T | 1.06T | 1.06T | 925.97B | 866.57B | Total Debt |
296.68B | 196.31B | 190.26B | 169.84B | 132.57B | Net Debt |
183.75B | -120.20B | 45.73B | 60.63B | 15.84B | Total Liabilities |
1.02T | 997.58B | 996.09B | 863.19B | 805.27B | Stockholders Equity |
61.45B | 61.15B | 59.03B | 62.78B | 61.29B |
Cash Flow | Free Cash Flow | |||
-37.22B | -27.89B | 27.14B | -99.00M | 32.92B | Operating Cash Flow |
-35.78B | -26.70B | 28.22B | 759.00M | 33.89B | Investing Cash Flow |
4.69B | -4.21B | -8.70B | -3.69B | -702.00M | Financing Cash Flow |
9.92B | 6.98B | 6.01B | -22.05B | -16.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $120.90B | 8.53 | 13.25% | 3.13% | 0.27% | 19.44% | |
77 Outperform | $56.39B | 9.34 | 13.70% | 3.83% | 18.85% | 14.85% | |
77 Outperform | $87.31B | 7.80 | 19.22% | 6.08% | 19.48% | 26.26% | |
76 Outperform | $66.11B | 9.94 | 11.92% | 12.93% | -0.63% | -6.01% | |
74 Outperform | $62.34B | 8.91 | 9.36% | 3.11% | 11.33% | 47.74% | |
66 Neutral | $77.67B | 17.53 | 11.51% | 4.30% | 21.13% | -5.96% | |
64 Neutral | $12.85B | 9.81 | 7.79% | 78.20% | 12.23% | -7.93% |